LAUSR

Coronavirus disease 2019 (COVID-19) has been associatedwith a wide spectrum of symptoms, and neurological complications characterized by anosmia, hypogeusia, seizures, hemorrhagic stroke, neuromuscular problems, and encephalopathy have been reported in over 30% of cases.1 The pathogenesis is still unclear, although underlying genetic susceptibility, viral invasion, and cytokine storm may play a role.2 We describe a girl with COVID19eassociated encephalopathy characterized by focal seizures and central apnea. This 14-year-old girl with no prior medical history presented with six days of fever, nasal congestion, and myalgia, followed by three generalized tonic-clonic seizures with perioral cyanosis. The patient was initially lethargic, but otherwise had a normal neurological examination. She had ongoing hypoxia and chest x-ray revealed bilateral infiltrates; she subsequently tested positive for COVID-19 polymerase chain reaction via nasopharyngeal sampling. Laboratory evaluation was unremarkable, cerebrospinal fluid profile and culture were normal, and cerebrospinal fluid polymerase chain reaction for COVID-19 was negative. The patient was started on levetiracetam and a 10-day course of remdesivir. Two days after admission, she experienced two apneic episodes, necessitating intubation. Electroencephalography monitoring